| Literature DB >> 26975996 |
Guus G H van den Akker1,2,3, Don A M Surtel1, Andy Cremers1, Martijn F G A Hoes2, Marjolein M Caron1, Stephen M Richardson4, Ricardo Rodrigues-Pinto4,5, Lodewijk W van Rhijn1, Judith A Hoyland4,6, Tim J M Welting1, Jan Willem Voncken7.
Abstract
BACKGROUND: Immediate early genes (IEGs) encode transcription factors which serve as first line response modules to altered conditions and mediate appropriate cell responses. The immediate early response gene EGR1 is involved in physiological adaptation of numerous different cell types. We have previously shown a role for EGR1 in controlling processes supporting chondrogenic differentiation. We recently established a unique set of phenotypically distinct cell lines from the human nucleus pulposus (NP). Extensive characterization showed that these NP cellular subtypes represented progenitor-like cell types and more functionally mature cells.Entities:
Keywords: Cell line; Differentiation; EGR1; IL-1β; Inflammation; Intervertebral disc; Nucleus pulposus; Specific cell responses
Mesh:
Substances:
Year: 2016 PMID: 26975996 PMCID: PMC4791893 DOI: 10.1186/s12891-016-0979-x
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
rtPCR primer sets for gene expression measurements
| Symbol | Forward primer | Reverse primer |
|---|---|---|
| ADAMTS4 | GGTCATGTCTTCAACATGCTCC | AGGATCCACATGAGCCATCAC |
| COL1A1 | TGGAGAGTACTGGATTGACCCC | TGCAGAAGACTTTGATGGCATC |
| COL2A1 | TGGGTGTTCTATTTATTTATTGTCTTCCT | GCGTTGGACTCACACCAGTTAGT |
| COX2 | ACCAACATGATGTTTGCATTCTTT | GGTCCCCGCTTAAGATCTGTCT |
| EGR1 | TGACCGCAGAGTCTTTTCCT | TGGGTTGGTCATGCTCACTA |
| KRT19 | GCAGTCACAGCTGAGCATGAA | TCCGTTTCTGCCAGTGTGTCT |
| MMP3 | TGATGAACAATGGACAAAGGATACA | TTTCATGAGCAGCAACGAGAA |
| SOX9 | AGTACCCGCACCTGCACAAC | CGCTTCTCGCTCTCGTTCAG |
| T | CCACCTGCAAATCCTCATCCT | TTGGAGAATTGTTCCGATGAG |
| TNFα | TCAATCGGCCCGACTATCTC | CAGGGCAATGATCCCAAAGT |
| VCAN | TCCCTCACTGTGGTCAAG | GTGTGTACCTGCTGGTTG |
| βACT | CCTGGCACCCAGCACAAT | GCCGATCCACACGGAGTACT |
| CYCLO | CCTGCTTCCACCGGATCAT | CGTTGTGGCGCGTAAAGTC |
| EIF2B1 | TGTCAGGTAAGAAAATGGCCAAA | TGTAGCCGACAGCAGCATCT |
| MRPL19 | CGCCGAAACCGGTCATC | TCCCCTTCGAGGAATGAATTC |
Fig. 1Induction of EGR1 expression in IVD cell lines. a Basal expression of EGR1 mRNA in representative clones (AF-123, NP-nR 105 and NP-R 115). Gene expression was normalized to Cyclophillin B and is presented relative to the NP-R clone. b Insulin, Transferrin and selenite (ITS; 10 μg/ml insulin, 10 μg/ml transferrin and 3 × 10−8M sodium selenite) and Valproic acid (0.3 mM) were used to stimulate IVD cell lines for 0, 2, 4 and 8 h. Gene expression of EGR1 was normalized to Cyclophillin B and is presented relative to the t = 0 time point. Bars represent a biological triplicate. c Protein expression of EGR1 under basal conditions and in response to stimulation with chondrogenic media for two hours. AF, NP-nR and NP-R samples were run on the same gel to allow direct comparison. The indication (t+) points to a long apposition time. Βeta Actin (βACT) was used as loading control; asterisks indicate significantly different expression level; p < 0.05
Fig. 2Cytokines induce catabolic response in the mature NP subclones. a Heatmap representation of gene expression changes in distinct NP subclones. NP cell clones NP-nR 105 and NP-R 124 were stimulated for two days with anabolic factors TGFβ3 (10 ng/ml), GDF6 (100 ng/ml), CTGF (100 ng/ml) or catabolic factors IL-1β (10 ng/ml) or TNFα (50 ng/ml). mRNA levels for the following genes was determined: KRT19, T, COL2A1, SOX9, VCAN, COL1A1, MMP3 and ADAMTS4. Gene expression was normalized to the average of EIF2B1 and MRPL19 expressions. Fold induction was calculated by comparison to untreated cells at day 2 and is represented in a heatmap; n.d.: not determined. Asterisks indicate significantly different expression level; p < 0.05. b Protein expression of EGR1 in response to maintenance medium (med), differentiation medium (diff), IL-1β (10 and 100 ng/ml) or Valproic acid (0.3 and 1 mM). NP-nR 105 and NP-R 115 samples were run on the same gel to allow direct comparison. The indication (t+) points to relatively long apposition times. Β Actin was used as loading control. c Three NP-nR and three NP-R clones were either left undisturbed (con), exposed to a change of maintenance medium (med) or medium supplemented with IL-1β (10 ng/ml) for two hours. Non-stimulated cells at time point t = 0 were used as control (con). Βeta Actin (βACT) was used as loading control
Fig. 3Confirmation loss of EGR1 function. a NP-nR and NP-R clones were transfected with 30 nM siRNAs targeting EGR1 (E) or control (C) siRNA. Sixteen hours after transfection cells were harvested (time point t = 0) and stimulated with IL-1β for 2 and 48 h. Immunoblotting for EGR1 reveals efficient knock-down of EGR1 at two hours post stimulation in both cell lines. Βeta Actin (βACT) was used as loading control. b Basal expression of COX2, TNFα, MMP3, and ADAMTS4 genes implicated in disc degeneration at t0. Gene expression was normalized to Cyclophillin B; asterisks indicate significantly different expression level; p < 0.05. c In silico representation of the promotor region of genes implicated in disc degeneration (Genomatix software; http://www.genomatix.de). Putative transcription factor (TF) binding sites for EGR family members are depicted by yellow boxes; high-probability EGR binding sites are indicated by black/bold print arrow heads, low-probability binding sites by light grey/normal print. Black arrows indicate the transcription start site
Fig. 4EGR1 controls inflammatory responses in IVD cell clones. Induction of COX2 (a) TNFα (b) MMP3 (c) and ADAMTS4 (d) expression measured by qPCR. Sixteen hours after siRNA transfection cells were harvested (time point t = 0) and stimulated with IL-1β for 2 and 48 h. Induced mRNA levels are expressed relative (FC) to siCTRL, t = 0, for each cell type. Double asterisks (**) indicate significantly different expression levels between siCTRL and siEGR1 measurements at the indicated time points (p < 0.05); single asterisks (*) indicate significance (p < 0.05) compared to time point t = 0 of that series (siCTRL or siEGR1)
Fig. 5EGR1 expression is increased in degenerate NP cells. a Immunodetection of EGR1-positive cells in healthy control NP tissue (L1/L2 IVD of a 63 years old donor; left panel) and in degenerate NP tissue (L4/L5 IVD of the same donor middle panel); right panel: staining control on degenerate NP section: primary antiserum detecting EGR1 was left out. b Quantification of EGR+ cell numbers in healthy or degenerate NP tissue. Cell numbers are depicted as percentage of total cell number scored (total cell counts: 121 for healthy tissue and 218 for degenerate tissue)